This article presents a formula for modeling the lifetime incidence of cancer in humans. The formula utilizes a Poisson distribution-based “np” model to predict cancer incidence, with “n” representing the effective number of cell turnover and “p” representing the probability of single-cell transformation. The model accurately predicts the observed incidence of cancer in humans when a reduction in cell turnover due to aging is taken into account. The model also suggests that cancer development is ultimately inevitable. The article proposes a theory of aging based on this concept, called the “np” theory. According to this theory, an organism maintains its order by balancing cellular entropy through continuous proliferation. However, cellular “information entropy” in the form of accumulated DNA mutations increases irreversibly over time, restricting the total number of cells an organism can generate throughout its lifetime. When cell division slows down and fails to compensate for the increased entropy in the system, aging occurs. Essentially, aging is the phenomenon of running out of predetermined cell resources. Different species have evolved separate strategies to utilize their limited cell resources throughout their life cycle.
1 November 2014 in Human Vaccines & Immunotherapeutics
Despite considerable progress in the development of immunocompetent mouse models using different high end technologies, most available small animal models for HCV study are unsuitable for challenge experiments, which are vital for vaccine development, as they fail to measure the T cell response in liver. A recently developed intra-hepatic challenge model results in HCV antigen expression in mouse hepatocytes and through the detection of the surrogate marker, SEAP, in serum, the effect of prior vaccination can be monitored longitudinally.
This article presents a formula for modeling the lifetime incidence of cancer in humans. The formula utilizes a Poisson distribution-based “np” model to predict cancer incidence, with “n” representing the effective number of cell turnover and “p” representing the probability of single-cell transformation. The model accurately predicts the observed incidence of cancer in humans when cell turnover reduction is taken into account. The model also suggests that cancer development is ultimately inevitable. The article proposes a theory of aging based on this concept, called the “np” theory (Nuts Poisoned). According to this theory, an organism maintains its order by balancing cellular entropy through continuous proliferation. However, cellular information entropy increases irreversibly over time, restricting the total number of cells an organism can generate throughout its lifetime. When cell division slows down and fails to compensate for the entropy increase of the system, aging occurs. Essentially, aging is the phenomenon of running out of predetermined cell resources. Different species have evolved separate strategies to utilize their limited cell resources throughout their life cycle.
Aging remains one of the most complex phenomena in biology, giving rise to a diverse range of theoretical frameworks aimed at elucidating its mechanisms. These theories often overlap, exhibiting both consistencies and contradictions, making it challenging to systematically categorize them. In this review, we revisit prominent aging theories from multiple perspectives. First, from the classical viewpoints of “wear-and-tear” and “programmed” aging, we introduce several foundational theories, including the oxidative damage family theories and information theory. We then examine these theories from an evolutionary perspective, which leads to the antagonistic pleiotropy (AP) theory and the hyperfunction theory. Following the mechanistic discussion, we consider several inclusive theories, including the “np” theory. Analogies are used throughout, and each section concludes with a philosophical reflection on the essence of aging. All discussions are centered on a fundamental question: “Is lifespan constrained by what nature does not pursue, or by what it fundamentally cannot achieve?” At least according to the “np” theory, an ultimate restriction stems from the information entropy. Finally, we highlight emerging rejuvenation strategies, which provide alternative lens to view aging theories. This review aims to inspire readers to think critically about current theories and to explore novel conceptual frameworks in the biology of aging.
Objectives: CAR-T cells are being investigated as a novel immunotherapy for glioblastoma, but clinical success has been limited. We recently described fibroblast activation protein (FAP) as an ideal target antigen for glioblastoma immunotherapy, with expression on both tumor cells and tumor blood vessels. However, CAR-T cells targeting FAP have never been investigated as a therapy for glioblastoma. Methods: We generated a novel FAP targeting CAR with CD3ζ and CD28 signaling domains and tested the resulting CAR-T cells for their lytic activity and cytokine secretion function in vitro (using real-time impedance, flow cytometry, imaging, and bead-based cytokine assays), and in vivo (using a xenograft mimicking the natural heterogeneity of human glioblastoma). Results: FAP-CAR-T cells exhibited target specificity against model cell lines and potent cytotoxicity against patient-derived glioma neural stem cells, even when only a subpopulation expressed FAP, indicating a bystander killing mechanism. Using co-culture assays, we confirmed FAP-CAR-T cells mediate bystander killing of antigen-negative tumor cells, but only after activation by FAP-positive target cells. This bystander killing was at least partially mediated by soluble factors and amplified by IL-2 which activated the non-transduced fraction of the CAR-T product. Finally, a low dose of intravenously administered FAP-CAR-T cells controlled, without overt toxicity, the growth of subcutaneous tumors created using a mixture of antigen-negative and antigen-positive glioblastoma cells. Conclusions: Our findings advance FAP as a leading candidate for clinical CAR-T therapy of glioblastoma and highlight under-recognized antigen non-specific mechanisms that may contribute meaningfully to the antitumor activity of CAR-T cells.